Podcast Family, we have covered the subject of Measles previously on this show (links below). Those episodes were a preview of what has now been released ahead of print as a narrative review in the G…
Published on 7 hours ago
The term "hypnosis" was first described in 1843 by Scottish surgeon James Braid, who published the book Neurypnology. He coined the term "hypnosis" from the Greek word for sleep to describe the tranc…
Published on 4 days, 11 hours ago
Well, from time to time we cover RANDOM tidbits of information which cover RANDOM questions and/or RANDOM patient care issues that we encounter. In this episode we will cover one OB issue related to …
Published on 5 days, 5 hours ago
On August 15, 2025, we reviewed the data from an FDA expert panel calling on the FDA to remove the exiting Black Box warning on commercial HRT options for menopausal care. In a historic decision, thi…
Published on 6 days, 13 hours ago
The ACOG acknowledges that maternal obesity affects labor curves and recommends allowing more time for cervical dilation before diagnosing labor arrest in obese patients. This approach aims to avoid …
Published on 1 week ago
Do you routinely order prophylactic antibiotics at time of second-degree laceration repair? Is there data for that? While the use of prophylactic antibiotics “is reasonable” (per ACOG PB 198) for OAS…
Published on 1 week, 3 days ago
On March 29, 2023, we released an episode titled, “The 4 PCOS Phenotypes”. That was in 2023! Now, on 29 October 2025, in the journal Nature Medicine, researchers have published, “Data-driven (FOUR) s…
Published on 1 week, 5 days ago
Taking folic acid prior to conception and during pregnancy can help protect the unborn baby from developing abnormalities. Supplements are particularly important for women who have epilepsy, as anti-…
Published on 2 weeks ago
Back on August 9, 2024, we released an episode (link in the show notes) reviewing the renewed interest in transfusing whole blood for PPH rather than component therapy. Now, in O&G open, authors from…
Published on 2 weeks, 2 days ago
Elinzanetant, sold under the brand name Lynkuet, received approval from the U.S. Food and Drug Administration (FDA) on October 24, 2025, for the treatment of moderate to severe hot flashes due to men…
Published on 2 weeks, 3 days ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate